angiogenin and Carcinoma--Embryonal

angiogenin has been researched along with Carcinoma--Embryonal* in 2 studies

Other Studies

2 other study(ies) available for angiogenin and Carcinoma--Embryonal

ArticleYear
Angiogenin prevents serum withdrawal-induced apoptosis of P19 embryonal carcinoma cells.
    The FEBS journal, 2010, Volume: 277, Issue:17

    Angiogenin is a 14 kDa protein originally identified as an angiogenic protein. Recent development has shown that angiogenin acts on both endothelial cells and neuronal cells. Loss-of-function mutations in the coding region of the ANG gene have recently been identified in patients with amyotrophic lateral sclerosis. Angiogenin has been shown to control motor neuron survival and protect neurons from apoptosis under various stress conditions. In this article, we characterize the anti-apoptotic activity of angiogenin in pluripotent P19 mouse embryonal carcinoma cells. Angiogenin prevents serum withdrawal-induced apoptosis. Angiogenin upregulates anti-apoptotic genes, including Bag1, Bcl-2, Hells, Nf-kappab and Ripk1, and downregulates pro-apoptotic genes, such as Bak1, Tnf, Tnfr, Traf1 and Trp63. Knockdown of Bcl-2 largely abolishes the anti-apoptotic activity of angiogenin, whereas the inhibition of Nf-kappab activity results in a partial, but significant, inhibition of the protective activity of angiogenin. Thus, angiogenin prevents stress-induced cell death through both the Bcl-2 and Nf-kappab pathways.

    Topics: Animals; Apoptosis; Carcinoma, Embryonal; Caspases; Culture Media, Serum-Free; Cytochromes c; Gene Expression Regulation, Neoplastic; Mice; NF-kappa B; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Ribonuclease, Pancreatic; Tumor Cells, Cultured

2010
A new role for angiogenin in neurite growth and pathfinding: implications for amyotrophic lateral sclerosis.
    Human molecular genetics, 2007, Jun-15, Volume: 16, Issue:12

    Mutations in human angiogenin (hANG), an angiogenic member of the RNase A superfamily, have been recently reported in patients with amyotrophic lateral sclerosis (ALS), a progressive late-onset neurodegenerative disorder. However, very little is known about the expression and subcellular distribution of ANG in the nervous system or its role in differentiation. Here we report that mouse angiogenin-1 (mAng-1) is strongly expressed in the developing nervous system during mouse embryogenesis and neuroectodermal differentiation of pluripotent P19 embryonal carcinoma cells. mAng1 is strongly expressed in motor neurons (MNs) in the spinal cord and dorsal root ganglia as well as in post-mitotic MNs derived from P19 cells. We also show for the first time that ANG expression is in the growth cones and neurites. NCI 65828, an inhibitor of the ribonucleolytic activity of hANG, affected pathfinding by P19-derived neurons but not neuronal differentiation. Our findings clearly show that ANG plays an important role in neurite pathfinding and this has implications for ALS.

    Topics: Amyotrophic Lateral Sclerosis; Animals; Carcinoma, Embryonal; Cell Differentiation; Embryo, Mammalian; Female; Fluorescent Antibody Technique; Male; Mice; Mice, Inbred C57BL; Naphthalenesulfonates; Neurites; Ribonuclease, Pancreatic; Tretinoin; Tumor Cells, Cultured

2007